FindTrial
Sign In

Identification of novel stratification markers and therapeutic targets of breast cancer based on epigenomic information

Identification of novel stratification markers and therapeutic targets of breast cancer based on epigenomic information - epigenomic analysis of breast cancer

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000035334
Enrollment
100
Registered
2019-01-01
Start date
2019-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

Japanese Foundation for Cancer Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: It is judged clinically that a mammary gland histologic examination (needle biopsy, mammotome biopsy, excisional biopsy) is necessary, or resection of the mammary gland (tumor resection, partial breast excision, mastectomy) is necessary as a treatment Case Age at registration is over 20 years old Regarding participation in this study, written informed consent has been obtained from the patient himself / herself

Exclusion criteria

Exclusion criteria: Case doctors judge that participation in this study is inappropriate

Design outcomes

Primary

MeasureTime frame
therapeutic response, prognosis—

Countries

Japan

Contacts

Public ContactReo Maruyama

Japanese Foundation for Cancer Research Project for Cancer Epigenomics, Cancer Institute

reo.maruyama@jfcr.or.jp03-3520-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026